Welcome to our dedicated page for Walgreens Boots Alliance SEC filings (Ticker: WBA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Walgreens Boots Alliance's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Walgreens Boots Alliance's regulatory disclosures and financial reporting.
Walgreens Boots Alliance, Inc. filed a Form 15 to terminate the registration of certain securities under Section 12(g) of the Securities Exchange Act of 1934 and to suspend its duty to file ongoing reports under Sections 13 and 15(d). The filing covers the company’s common stock with a par value of $0.01 per share and multiple series of Walgreens Boots Alliance, Inc. and Walgreen Co. notes maturing between 2025 and 2050. The certification is signed on behalf of the company by Lanesha Minnix, Executive Vice President, Global Chief Legal Officer and Corporate Secretary.
Silver Point Capital and two principals filed a Schedule 13G regarding Walgreens Boots Alliance (WBA). The filing states that as of August 27, 2025 the Reporting Persons beneficially owned 60,061,000 shares, representing 6.9% of 865,560,675 shares outstanding (per the issuer's June 19, 2025 count). The issuer completed a merger on August 28, 2025 and the Reporting Persons' shares were converted into the stated Per Share Consideration. The cover pages list 0 shares beneficially owned at filing, reflecting that conversion. The Schedule is jointly filed by Silver Point Capital, L.P., Edward A. Mule and Robert J. O'Shea and includes a Joint Filing Agreement.
Senior Vice President and Chief Corporate Affairs Officer Beth Amber L. Fabbri reported a disposition of 124,670 shares of Walgreens Boots Alliance, Inc. common stock on 08/28/2025. The filing shows 0 shares beneficially owned following the reported transaction. The disposal reflects cancellation of restricted stock units (including dividend-equivalent RSUs) in connection with the merger described in the filing: at the merger's effective time each share of common stock was converted into $11.45 in cash plus one divested asset proceed right. The filing notes that consideration for any RSUs that were unvested at the effective time remains subject to continued employment-based vesting conditions.
Manmohan Mahajan, EVP and Global CFO of Walgreens Boots Alliance (WBA), reported a transaction dated 08/28/2025 disposing of 414,273 shares of WBA common stock, leaving him with 0 shares beneficially owned following the transaction. The Form 4 explains the disposition resulted from the Merger under the March 6, 2025 Merger Agreement, where each share was converted at the Effective Time into $11.45 in cash plus one Divested Asset Proceed Right. RSUs held by the reporting person were cancelled in exchange for the Per Share Consideration, although any unvested RSUs remain subject to the original vesting conditions tied to continued service.
Lanesha Minnix, EVP, Global CLO & Corporate Secretary of Walgreens Boots Alliance (WBA), reported the automatic disposition of 348,093 shares of WBA common stock on 08/28/2025 as a result of the closing of a merger. Under the Merger Agreement, each WBA share converted into $11.45 cash per share plus one divested asset proceed right. All RSUs held by the reporting person were cancelled and exchanged for the per-share consideration; payment for any unvested RSUs remains subject to the holder’s continued employment and prior vesting conditions. Following the transaction the reporting person beneficially owns 0 shares of WBA common stock.